It's not just (or even predominantly) patent law: if there is no explicit or implicit agreement for FDA to approve some treatments that modulate ageing (to even

It's not just (or even predominantly) patent law: if there is no explicit or implicit agreement for FDA to approve some treatments that modulate ageing (to even become a possibility, this category of indications should be created) and for the healthcare provider complex (insurers, governments, clinics) to provide said treatments to the public, there is no prospective market. Until there is a coordinated push to align our regulatory and medical systems with this challenge, the status quo will remain frozen. Will a few remaining decades be enough for the metaphorical ice to crack?